Trial Profile
Adherence-Suppression-Resistance Relationships for Atripla [efavirenz/emtricitabine/tenofovir-disoproxil-fumarate] Compared to Historical Antiretroviral Regimens
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2012
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 09 Nov 2009 New trial record